Trial Profile
Feasibility and efficacy of Lenalidomide maintenance after salvage immuno-chemotherapy induction in relapsed or refractory mantle cell lymphoma - a phase II study of the European MCL Network.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2012
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Mantle-cell lymphoma
- Focus Adverse reactions
- 28 Jul 2011 New trial record